Case Reports

Mind the Gap: Case Study in Toxicology


 

References

How are patients exposed to bromide salts?

Bromide salts, specifically sodium bromide, are infrequently used to treat seizure disorders, but are generally reserved for patients with epilepsy refractory to other, less toxic anticonvulsant medications. During the era when bromide salts were more commonly used to treat epilepsy, bromide intoxication, or bromism, was frequently observed.

Bromism may manifest as a constellation of nonspecific neurological and psychiatric symptoms. These most commonly include headache, weakness, agitation, confusion, and hallucinations. In more severe cases of bromism, stupor and coma may occur.3,5

Although bromide salts are no longer commonly prescribed, a number of products still contain brominated ingredients. Symptoms of bromide intoxication can occur with chronic use of a cough syrup containing dextromethorphan hydrobromide as well as the brominated vegetable oils found in some soft drinks.5

How is bromism treated?

The treatment of bromism involves preventing further exposure to bromide and promoting bromide excretion. Bromide has a long half-life (10-12 days), and in patients with normal renal function, it is possible to reduce this half-life to approximately 3 days with hydration and diuresis with sodium chloride.3 Alternatively, in patients with impaired renal function or severe intoxication, hemodialysis has been used effectively.5

Case Conclusion

The patient was admitted for observation and treated with intravenous sodium chloride. After consultation with his neurologist, he was discharged home in the care of his parents, who were advised to continue him on sodium bromide 185 mg orally twice daily since his seizures were refractory to other anticonvulsant medications.

Dr Repplinger is a medical toxicology fellow in the department of emergency medicine at New York University Langone Medical Center. Dr Nelson, editor of “Case Studies in Toxicology,” is a professor in the department of emergency medicine and director of the medical toxicology fellowship program at the New York University School of Medicine and the New York City Poison Control Center. He is also associate editor, toxicology, of the EMERGENCY MEDICINE editorial board.

Pages

Recommended Reading

Environmental factors could increase U.S. anthrax cases
MDedge Emergency Medicine
Heroin overdoses up dramatically since 2010
MDedge Emergency Medicine
FDA approves Anthrasil to treat inhalational anthrax
MDedge Emergency Medicine
HHS secretary tells how to combat drug abuse
MDedge Emergency Medicine
Illicit drug use highest in accommodations and food service workers
MDedge Emergency Medicine
Fatal opioid overdoses down dramatically since 2010
MDedge Emergency Medicine
Malpractice Counsel
MDedge Emergency Medicine
U.S. poison center calls nearly quadrupled because of fake pot
MDedge Emergency Medicine
Docs need all tools, better education to combat opioid addiction
MDedge Emergency Medicine
Malpractice Counsel
MDedge Emergency Medicine